"Oh, The Changes I’ve Seen" - Op Ed by Bob Riter

I was diagnosed with breast cancer thirty years ago and I’ve attended dozens of national cancer research conferences since then.

It’s a useful exercise to step back from time to time and look at the big picture. What’s changed in our understanding of cancer and cancer treatment in those three decades? (Note that this article isn’t specific to male breast cancer).

Here are some of the broad themes:

Targeted Therapies

Thirty years ago, chemotherapy used a shotgun approach. Shoot and hope for the best. It wasn’t generally clear who would benefit from chemotherapy, so we gave it to most people, hoping that those who could benefit from it would benefit, and those that didn’t benefit weren’t terribly damaged by it.

Today, we’re much better able to match the drug(s) to the biology of the specific tumor. In the first national conference that I attended - the San Antonio Breast Cancer Symposium - Dr. Dennis Slamon presented the results of a trial of trastuzumab (Herceptin) which proved to be remarkably effective in the treatment of Triple Negative Breast Cancers. This was one of the first targeted cancer treatments.

Targeted treatments are wonderful because the individuals with that biological target are likely to benefit. Equally important is an understanding of who won’t benefit from that treatment.

Deescalation of Treatment

We’ve slowly evolved from thinking that the most aggressive cancer treatment is always the best cancer treatment. I’ve seen this in the surgical removal of axillary lymph nodes. Thirty years ago, it was common to have a complete axillary dissection as a routine part of any mastectomy or lumpectomy. A few years later, sentinel lymph node dissection became the standard of care and additional nodes were removed only if the sentinel nodes were positive. More recently, it’s been discovered that removing a small number of positive nodes does not provide additional benefit and a complete axillary dissection is only performed if there’s extensive axillary involvement. We increasingly realize that less treatment is often better treatment.

The Tumor Microenvironment

For most of history, our research focus has been on the biology of the cancer tumor. Over the past decade or so, we’re increasingly aware of the importance of what surrounds the tumor. (This is often referred to as the tumor microenvironment). That environment impacts the ability of the tumor to spread, and also affects the ability of drugs to reach the tumor. Immunotherapy has been one of the most important advances in cancer therapy for the past couple of decades, and it specifically activates and deactivates immune cells in that microenvironment.

Cancer as an Evolutionary Process

Finally, we’re increasingly thinking of cancer in evolutionary terms. Cancer cells constantly multiply and only the “fittest” cancer cells manage to take root in other organs. Further, while cancer treatments generally kill most cancer cells, the cancer cells that remain are - by definition - the most resistant to treatment, and those cells are the ones that continue to multiply. In the future, treatments may be designed with evolution in mind. Some cancers might be better controlled not by attempting to kill every cancer cell, but by “managing” the populations of cancer cells that are sensitive and those that are resistant to treatment.

Our knowledge of cancer continues to evolve. Had I been diagnosed today instead of in 1996, my treatment would have been quite different. I would have had a sentinel node biopsy (instead of a complete axillary dissection), and I likely would not have had chemotherapy given my tumor biology. But that’s the nature of science. We know more and treatments will continue to improve and be more personalized to each individual. I’m excited to see the changes that will take place in the next thirty years.

Advancing Research. Empowering Advocates. Changing the Future of Male Breast Cancer.

The Male Breast Cancer Global Alliance (MBCGA) Research Committee is where science, patient advocacy, and collaboration come together to accelerate progress against male breast cancer. Committed to evidence-based decision-making, the committee serves as a trusted voice in evaluating emerging research, supporting promising scientific initiatives, and ensuring that the unique needs of men with breast cancer are represented throughout the research process.

Committee members work alongside leading investigators, pharmaceutical trial teams, clinicians, and advocacy organizations to review research proposals, contribute valuable patient perspectives, promote educational programs, and mentor the next generation of research advocates. The committee also helps ensure that MBCGA educational resources remain aligned with the latest scientific evidence while encouraging greater participation in nationally recognized advocacy training programs.

Whether you are a survivor, caregiver, healthcare professional, or advocate passionate about advancing research, the MBCGA Research Committee offers a meaningful opportunity to make a lasting impact. By connecting lived experience with scientific discovery, the committee is helping shape better treatments, stronger collaborations, and a brighter future for every man affected by breast cancer. Together, we can transform advocacy into action and research into hope.

Bob Riter

My organizational connections:

• Advocates for Collaborative Education (ACE) (Communications Chair)
• Susan G. Komen Advocates in Science (Steering Committee)
• Male Breast Cancer Global Alliance (Advocate Research Committee)

Writings:

• Books by Bob Riter
• "Making the most of cancer: My journey from diagnosis to advocate" (An essay on the Living Beyond Breast Cancer website).
• The Bridge Builder (from Cancer Today)

Spotlight: Dr. Neil M. Iyengar, MD

SFOR INTERNAL USE ONLY: NOT FINAL FOR PUBLISHING 

The Emerging Role of Metabolic Health in Male Breast Cancer Research

Reflections Following a Strategic Meeting Between the Male Breast Cancer Global Alliance and Emory University

By Lennard M. Goetze, Ed.D.
Executive Director, AngioInstitute

On June 10, 2026, representatives of the Male Breast Cancer Global Alliance (MBCGA) met with Dr. Neil M. Iyengar, MD, breast medical oncologist, physician-scientist, and Director of Survivorship Services at Emory University's Winship Cancer Institute. The meeting was organized by Cheri Ambrose, CEO of the Male Breast Cancer Global Alliance, as part of the organization's continuing effort to engage leading investigators whose work has the potential to influence the future direction of breast cancer research, survivorship, and patient-centered care.

Participants included Dr. Robert L. Bard, Chief Clinical Advisor to MBCGA; Daniel Root, Associate Director of Communications; and Lennard M. Goetze, Ed.D., representing the AngioInstitute and its affiliated research and publishing initiatives. The primary purpose of the meeting was to discuss emerging research priorities in breast oncology, explore opportunities for collaborative investigation, and formally invite Dr. Iyengar to join the Medical Advisory Board of the Male Breast Cancer Global Alliance.

The invitation was motivated not only by Dr. Iyengar's clinical expertise, but also by his increasingly influential body of work examining the relationship between metabolic health, lifestyle factors, and cancer outcomes.

Expanding the Framework of Breast Cancer Research

Traditional oncology has historically focused on the biological characteristics of tumors themselves. Increasingly, however, researchers are recognizing that tumor behavior cannot be fully understood without examining the physiologic environment in which malignancies develop and progress.

Dr. Iyengar's research program reflects this broader perspective. During the discussion, he described his work as focusing on "the intersections of metabolic health and lifestyle with both cancer risk and cancer outcomes."

His investigations examine the role of obesity, insulin signaling, inflammation, adipose tissue biology, and body composition in cancer development and survivorship. These factors collectively influence what researchers increasingly describe as the tumor microenvironment—a dynamic ecosystem that may either promote or suppress malignant progression.

As Dr. Iyengar explained, most breast cancers arise within tissue environments dominated by adipose tissue. Consequently, the metabolic state of the individual becomes clinically relevant.

"Most breast tumors arise within a microenvironment that's predominantly comprised of fat cells," he noted. "Poor metabolic health and states of energy imbalance can change the tumor microenvironment in a way that supports tumor growth."

This line of investigation has significant implications for both prevention and survivorship. It suggests that interventions directed toward metabolic optimization may ultimately complement conventional treatment strategies by modifying biological conditions associated with disease progression.

From Survivorship to Prevention

Among Dr. Iyengar's most significant contributions has been his leadership in survivorship medicine. As Director of Survivorship Services at Winship Cancer Institute, he oversees the development and integration of evidence-based programs designed to address the long-term needs of cancer survivors. These initiatives extend beyond traditional follow-up care and incorporate nutrition, exercise, supportive care, behavioral interventions, and lifestyle modification.

His previous work at Memorial Sloan Kettering Cancer Center resulted in the development of the Healthy Living Program, an innovative survivorship model designed to create individualized wellness strategies for patients during and after cancer treatment.

Such efforts reflect a growing recognition that survivorship should not be viewed merely as the period following treatment. Rather, survivorship represents a continuum of care that begins at diagnosis and extends throughout the patient's lifespan.

This philosophy aligns with an expanding body of literature demonstrating that exercise, nutrition, body composition, and metabolic regulation may influence recurrence risk, treatment tolerance, quality of life, and overall survival.

Relevance to Male Breast Cancer

Although the majority of breast cancer research understandably focuses on women, male breast cancer remains an area of considerable unmet need. The rarity of the disease presents challenges for investigators seeking to conduct adequately powered studies. Consequently, many clinical recommendations for men are extrapolated from data generated in female populations.

Dr. Iyengar emphasized that such extrapolations may overlook important biological differences. "I have treated and still treat a lot of men with breast cancer," he stated. "The metabolic status of a male versus a post-menopausal female, for example, is very, very different."

This observation has substantial implications for future research. Differences in hormonal physiology, body composition, adipose tissue distribution, and metabolic regulation may influence both disease development and treatment response.

Accordingly, Dr. Iyengar noted that there is a need to examine these questions directly within male populations. "I really think that there's a need to study metabolic health specifically in men." His comments highlight a growing opportunity within male breast cancer research: the development of biologically informed investigations that move beyond simple adaptation of female-centered models.

Challenges in Rare Disease Research

The conversation also addressed one of the most persistent barriers facing male breast cancer investigators: patient recruitment. Dr. Iyengar described a prior research concept involving male breast cancer patients that encountered practical limitations because of anticipated accrual challenges.

"We thought the grant would be criticized for the ability to accrue 40 male breast cancer patients within two years at a single center." This challenge is not unique to male breast cancer. Rare diseases frequently require multi-institutional collaboration to achieve meaningful sample sizes.

The discussion therefore shifted toward opportunities for national recruitment networks, collaborative publishing initiatives, and multi-center research models capable of supporting future investigations. In this regard, the Male Breast Cancer Global Alliance serves an important function by connecting researchers, advocacy organizations, clinicians, survivors, and healthcare systems that may otherwise operate independently.

Survivorship Resources for Men

A particularly important observation emerged regarding survivorship programming. Dr. Iyengar noted that many existing exercise and wellness initiatives remain primarily designed around female breast cancer populations.

"A lot of the lifestyle programs for breast cancer—the diet and exercise programs—are really geared towards women," he explained. While these programs provide substantial value, their design may unintentionally limit engagement among male survivors. This observation reinforces the need for educational resources, rehabilitation programs, exercise interventions, and survivorship models specifically developed for men diagnosed with breast cancer.

As survivorship continues to evolve as a discipline, such considerations may become increasingly important components of comprehensive care.

Appointment to the Medical Advisory Board

Following discussion of these topics, Cheri Ambrose formally invited Dr. Iyengar to join the Medical Advisory Board of the Male Breast Cancer Global Alliance.

The invitation reflects recognition of his scholarly contributions to breast oncology, his leadership in survivorship medicine, and his commitment to advancing understanding of the relationship between metabolic health and cancer outcomes.

Dr. Iyengar accepted the invitation, expressing interest in participating in future educational and research initiatives. His appointment adds an important perspective to the advisory board, particularly in areas involving lifestyle medicine, survivorship science, metabolic health, and translational oncology.

Conclusion

The June 10 meeting highlighted several themes that are likely to influence the next generation of breast cancer research: precision lifestyle interventions, survivorship science, metabolic health, collaborative investigation, and the unique needs of men diagnosed with breast cancer.

Dr. Neil M. Iyengar's work occupies a strategic position at the intersection of these emerging disciplines. His research challenges investigators to look beyond the tumor itself and consider the broader biological, behavioral, and metabolic factors that shape cancer outcomes.

For the Male Breast Cancer Global Alliance, the addition of Dr. Iyengar to its Medical Advisory Board represents an opportunity to strengthen scientific dialogue surrounding an often-overlooked patient population. More importantly, it reflects a shared commitment to advancing evidence-based approaches that improve prevention, treatment, survivorship, and quality of life for individuals affected by breast cancer.

As male breast cancer research continues to mature, collaborative relationships between clinicians, scientists, advocacy organizations, and survivors will become increasingly essential. The June 10 discussion represents one step in that process and underscores the value of bringing together diverse expertise in pursuit of common goals.

-----------------------------------------------------------------------------------------------------------------------------

Three Decades of Progress: How Cancer Care Has Been Transformed

By: Bob Ritter

Bob Riter brings the rare perspective of someone who has lived through—and helped shape—three decades of cancer advocacy. In this compelling reflection, he explores the extraordinary evolution of cancer care, from the era of one-size-fits-all chemotherapy to today's precision medicine, targeted therapies, immunotherapy, and personalized treatment strategies. With insight drawn from years of attending leading research conferences, Riter explains how science continues to redefine what is possible while improving both outcomes and quality of life. His inspiring look back reminds us that every breakthrough builds hope for the next generation of patients and survivors. 

SEE COMPLETE FEATURE

Advancing Research. Empowering Advocates. Changing the Future of Male Breast Cancer.

The Male Breast Cancer Global Alliance (MBCGA) Research Committee is where science, patient advocacy, and collaboration come together to accelerate progress against male breast cancer. Committed to evidence-based decision-making, the committee serves as a trusted voice in evaluating emerging research, supporting promising scientific initiatives, and ensuring that the unique needs of men with breast cancer are represented throughout the research process.

Committee members work alongside leading investigators, pharmaceutical trial teams, clinicians, and advocacy organizations to review research proposals, contribute valuable patient perspectives, promote educational programs, and mentor the next generation of research advocates. The committee also helps ensure that MBCGA educational resources remain aligned with the latest scientific evidence while encouraging greater participation in nationally recognized advocacy training programs.

Whether you are a survivor, caregiver, healthcare professional, or advocate passionate about advancing research, the MBCGA Research Committee offers a meaningful opportunity to make a lasting impact. By connecting lived experience with scientific discovery, the committee is helping shape better treatments, stronger collaborations, and a brighter future for every man affected by breast cancer. Together, we can transform advocacy into action and research into hope.

Innovative Virtual Photography (IVP)

A New Era of Authentic Survivor Advocacy Through Artificial Intelligence

Public health communication has always relied on compelling imagery to educate, inspire, and motivate communities. Whether promoting early detection, survivorship, rehabilitation, or advocacy, the visual message often speaks louder than words. For organizations serving patients and survivors, authenticity is essential. Real stories deserve real faces.

The Male Breast Cancer Global Alliance (MBCGA) has embraced this philosophy by introducing an innovative communications platform known as Innovative Virtual Photography (IVP)—a proprietary imaging methodology that enables the creation of personalized, high-quality visual assets using artificial intelligence while preserving the identity and spirit of each participant.

IVP represents a new direction in nonprofit communications. Rather than relying on generic stock photography that may fail to accurately represent the communities being served, this technology allows MBCGA to feature actual male breast cancer survivors in campaigns throughout the year. The result is a library of authentic visual content that can be adapted for awareness campaigns, educational materials, fundraising initiatives, newsletters, social media, conference presentations, and public service announcements.

Every survivor has a story worth telling. IVP provides an innovative way to tell that story visually.  For advocacy organizations, visual consistency has traditionally been one of the greatest challenges. Organizing multiple professional photo shoots requires scheduling, travel, photographers, studio space, lighting, wardrobe coordination, and significant financial resources. These logistical obstacles often limit the diversity and quantity of available imagery.

Innovative Virtual Photography removes many of these barriers by combining remote participation with advanced artificial intelligence. Through a guided online session, survivors can contribute to a growing portfolio of personalized visual assets from virtually anywhere. Once established, this digital catalog can support future campaigns without requiring repeated photography sessions.

For the Male Breast Cancer Global Alliance, this means greater efficiency while maintaining the human connection that defines effective advocacy.

Unlike anonymous stock photographs, IVP celebrates the genuine faces of survivorship. Members of the public are more likely to connect with authentic individuals who have experienced diagnosis, treatment, recovery, and rehabilitation firsthand. These images communicate hope, resilience, and credibility because they represent the real people behind the mission.

This approach also strengthens community identity. Survivors become ambassadors for awareness, encouraging other men to seek education, screening, and support. Every campaign reinforces the message that male breast cancer is real, survivorship is possible, and no individual faces the journey alone.

How Does IVP Work?

The IVP process begins with a scheduled online video session, typically conducted through a secure Zoom meeting. During each session, Communications Director Lennard Goetze guides participants through a carefully designed sequence of facial expressions and viewing angles.

The process is intentionally simple and comfortable. Participants are asked to face the camera while performing a variety of natural expressions, including relaxed, smiling, laughing, thoughtful, serious, hopeful, and determined looks. Additional head positions include looking left, right, upward, downward, and at intermediate angles. These guided movements create a comprehensive visual reference of each participant's facial structure and expressions.

Throughout the session, high-resolution screen captures are obtained under consistent viewing conditions. These reference images provide the foundation for the participant's personalized digital profile.

Additional observations of upper-body proportions help establish approximate body dimensions, posture, and overall physique. Rather than requiring a complete professional photo session, these reference materials provide sufficient information for the next stage of production.

Using proprietary artificial intelligence technology, the software analyzes these visual references and generates an extensive range of image possibilities while preserving the recognizable identity of the individual survivor. Digital artists then refine the output by combining the participant's facial characteristics with an extensive catalog of anatomically appropriate body references, poses, gestures, wardrobe selections, environments, and lighting conditions. This hybrid workflow combines human artistic direction with advanced AI-assisted rendering.

The final images may portray survivors exercising during rehabilitation, speaking at conferences, participating in awareness walks, celebrating milestones, embracing family members, engaging in community outreach, or standing as symbols of hope during national awareness campaigns. Each illustration remains faithful to the participant's appearance while allowing virtually unlimited creative flexibility for educational storytelling.

The result is an expanding visual library capable of supporting communications throughout the year without repeated studio photography.

The advantages extend beyond efficiency. IVP dramatically reduces production costs while increasing creative possibilities. Campaigns can be developed more rapidly, adapted for seasonal awareness initiatives, or customized for specific educational topics. New posters, brochures, newsletters, websites, fundraising appeals, and social media graphics can be created using familiar survivor ambassadors who already represent the organization.

For the Male Breast Cancer Global Alliance, this technology supports an important philosophical goal: placing survivors—not anonymous models—at the center of every message.

Innovation in healthcare extends beyond diagnostics, treatment, and rehabilitation. It also includes how organizations communicate with the public. By embracing emerging technologies responsibly, advocacy organizations can strengthen education while preserving the human stories that inspire action.

Innovative Virtual Photography demonstrates how artificial intelligence can enhance—not replace—the human experience. Technology serves as a creative tool that amplifies authentic voices, allowing real survivors to continue educating the public long after a single photo session has ended.

As awareness campaigns become increasingly digital, organizations require flexible, scalable, and believable visual resources. IVP offers a practical solution that combines authenticity, efficiency, artistic creativity, and technological innovation into a single communications platform.

For the Male Breast Cancer Global Alliance, every image tells more than a story—it represents courage, resilience, hope, and the shared commitment to ensuring that no man faces breast cancer alone. Through Innovative Virtual Photography, survivors continue to educate, inspire, and advocate, one powerful image at a time.

Psychological Survivorship After Cancer Therapy

Understanding Mental Health Recovery Following Heavy Treatments

Jessica Connell, LCSW & Barbara Bartlik, MD

The completion of chemotherapy or radiation therapy has traditionally been regarded as the conclusion of active cancer treatment. From a clinical perspective, however, the termination of oncologic intervention frequently represents the beginning of a second phase of care known as survivorship. While contemporary oncology has made remarkable advances in improving disease-free survival and overall longevity, increasing attention has been directed toward the long-term psychological and neurocognitive consequences experienced by survivors. Mental health recovery has emerged as a critical component of comprehensive survivorship, requiring structured evaluation and interdisciplinary support comparable to physical rehabilitation.

Cancer is not solely a biological disease. It constitutes a prolonged psychological stressor that challenges nearly every dimension of an individual's functioning, including cognition, emotional regulation, interpersonal relationships, occupational performance, self-image, and existential perspective. Throughout treatment, patients frequently develop adaptive coping mechanisms focused upon immediate survival. Once treatment concludes, however, these protective mechanisms often give way to unresolved psychological distress that becomes increasingly apparent as individuals attempt to resume pre-diagnosis roles and responsibilities.

The prevalence of mental health concerns among cancer survivors is substantial. Anxiety disorders remain among the most commonly reported complications, often characterized by persistent fear of recurrence, heightened vigilance toward normal bodily sensations, anticipatory distress surrounding surveillance imaging, and uncertainty regarding future health. Depressive symptoms may emerge concurrently, presenting as diminished motivation, impaired concentration, emotional withdrawal, loss of pleasure, fatigue disproportionate to physical recovery, and alterations in sleep architecture. While these symptoms vary considerably among individuals, they collectively illustrate that survivorship extends beyond remission to encompass long-term psychological adaptation.

An additional dimension of post-treatment recovery involves neurocognitive dysfunction commonly referred to as cancer-related cognitive impairment or "chemotherapy-associated cognitive dysfunction." Although colloquially described as "chemo brain," the phenomenon encompasses a broader constellation of impairments involving attention, executive functioning, processing speed, working memory, verbal recall, and multitasking ability. These changes may persist for months or, in some individuals, several years following treatment. Importantly, such cognitive disturbances are not solely attributable to chemotherapy itself but may also reflect cumulative effects of systemic inflammation, endocrine disruption, fatigue, emotional distress, sleep disturbances, concurrent medications, and the neurobiological consequences of chronic psychological stress.

These cognitive changes frequently produce secondary emotional consequences. Individuals who previously functioned at high professional or academic levels may experience frustration, embarrassment, diminished confidence, and concern regarding their ability to return to previous occupational responsibilities. Consequently, cognitive impairment often contributes indirectly to social isolation, vocational uncertainty, and reduced self-efficacy.

Cancer survivorship also requires substantial identity reconstruction. During treatment, patients commonly adopt the role of "cancer patient," with daily life organized around medical appointments, treatment schedules, diagnostic testing, and symptom management. Following completion of therapy, the abrupt withdrawal of this structured environment frequently creates psychological disequilibrium. Survivors often describe uncertainty regarding how to define themselves beyond illness, particularly when family members and colleagues assume that recovery is complete despite persistent emotional or cognitive difficulties. This discrepancy between external expectations and internal experience may further complicate psychological adjustment.

The restoration of mental health therefore requires deliberate intervention rather than passive observation. Contemporary survivorship models increasingly recognize psychological rehabilitation as an integral component of comprehensive cancer care. Early identification of anxiety, depression, adjustment disorders, trauma-related symptoms, sleep disorders, and cognitive dysfunction permits timely intervention before secondary complications develop.

Psychotherapeutic intervention represents one of the most effective strategies for facilitating psychological recovery. Individual psychotherapy provides survivors with a structured environment in which to process fear, grief, altered self-perception, and uncertainty regarding the future. Evidence-based approaches including Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), mindfulness-based cognitive therapy, supportive psychotherapy, and trauma-informed interventions have demonstrated measurable benefit in reducing emotional distress while improving adaptive coping mechanisms and quality of life. Equally important is psychoeducation, enabling survivors and their families to recognize that emotional and cognitive symptoms represent expected components of survivorship rather than indicators of personal weakness or treatment failure.

The process of cognitive rehabilitation similarly benefits from structured intervention. Neuroplasticity permits meaningful functional recovery through repeated cognitive engagement. Activities involving reading, memory exercises, strategic problem solving, language acquisition, executive functioning tasks, and computerized cognitive training may enhance neural efficiency while restoring confidence in cognitive performance. Occupational therapy and neuropsychological consultation may further assist survivors experiencing persistent deficits that interfere with vocational or daily functioning.

Lifestyle modification constitutes another essential component of psychological recovery. Physical activity has consistently demonstrated positive effects upon mood regulation, cognitive performance, sleep quality, inflammatory modulation, and overall neurological health. Nutritional optimization, restoration of circadian rhythm, adequate hydration, and management of chronic fatigue collectively contribute to improved psychological resilience. Equally important is the gradual re-establishment of meaningful social interaction, vocational engagement, recreational activities, and community participation, each of which reinforces a renewed sense of purpose and personal identity.

Confidence frequently represents the final domain to recover. Following months of medical intervention, many survivors develop understandable apprehension regarding physical symptoms, future health, or their capacity to resume previous responsibilities. Confidence cannot simply be restored through reassurance alone; rather, it develops progressively through repeated experiences of successful adaptation. Incremental achievement, realistic goal-setting, supportive therapeutic relationships, and ongoing clinical follow-up collectively strengthen an individual's belief in his or her capacity to function beyond the cancer experience.

Modern survivorship therefore requires a paradigm that extends beyond disease surveillance alone. Long-term outcome measures should encompass psychological well-being, cognitive functioning, vocational reintegration, interpersonal relationships, and overall quality of life in addition to traditional oncologic endpoints. As survival rates continue to improve across numerous malignancies, healthcare systems bear increasing responsibility for addressing the enduring emotional and neurocognitive consequences of treatment.

Survivorship should not be conceptualized as the absence of disease, but rather as the restoration of adaptive functioning across physical, psychological, cognitive, and social domains. Comprehensive recovery is achieved not only through successful eradication of cancer but through the preservation and rehabilitation of the individual's capacity to engage meaningfully with work, family, community, and personal purpose. Mental health is therefore not ancillary to survivorship care; it is one of its defining clinical outcomes.

PART 2

HOPE THROUGH REHABILITATION:

Rebuilding Quality of Life After Cancer Through Movement, Nutrition, and Preventive Imaging

By Robert L. Bard, MD

Cancer survivorship extends well beyond the successful completion of surgery, chemotherapy, or radiation therapy. While eliminating disease remains the primary objective of oncology, the restoration of physical function, emotional well-being, and long-term health has become an equally important component of comprehensive cancer care. Rehabilitation should therefore be regarded not as an optional service, but as a structured medical strategy designed to restore quality of life while reducing the risk of future health complications.

Cancer treatment frequently produces long-lasting physiological changes that include muscle deconditioning, chronic fatigue, neuropathy, reduced cardiovascular endurance, weight fluctuations, joint stiffness, and metabolic alterations. Left unaddressed, these consequences may significantly impair functional independence and diminish overall health despite successful cancer treatment. Rehabilitation provides survivors with an opportunity to reverse many of these effects through individualized interventions that promote recovery rather than simple maintenance.

Exercise represents one of the most extensively studied components of cancer rehabilitation. Carefully prescribed aerobic activity, resistance training, flexibility exercises, and balance conditioning have demonstrated benefits in improving muscular strength, cardiovascular fitness, mobility, fatigue, and overall physical performance. Equally important, regular physical activity contributes to improved immune function, healthier body composition, enhanced metabolic regulation, and better psychological resilience. Rehabilitation should therefore encourage consistent movement that is individualized according to each survivor's medical history, treatment-related limitations, and functional goals.

Nutrition constitutes another essential pillar of survivorship. Recovery requires adequate protein for tissue repair, anti-inflammatory dietary patterns, optimal hydration, and nutritional strategies that support immune function while reducing cardiovascular and metabolic risk factors. Rather than focusing solely upon weight management, nutritional rehabilitation should emphasize restoring physiological resilience and promoting long-term health across multiple organ systems.

An equally important component of survivorship is active surveillance. Rehabilitation is most effective when accompanied by objective monitoring of the body's ongoing recovery. Modern diagnostic imaging allows clinicians to evaluate musculoskeletal healing, vascular integrity, lymphatic function, soft tissue abnormalities, and other treatment-related changes before symptoms become clinically significant. Ultrasound, in particular, offers a safe, non-invasive, and repeatable method for assessing many superficial tissues without ionizing radiation, allowing clinicians to document recovery while identifying conditions that may benefit from early intervention.

Preventive imaging should not be viewed solely as a means of detecting recurrent malignancy. It also serves as an important instrument for evaluating the broader health of the cancer survivor. Identifying inflammation, fibrosis, musculoskeletal injury, vascular compromise, or treatment-related tissue changes at an early stage allows rehabilitation programs to be modified proactively rather than reactively.

The future of survivorship care lies in the integration of rehabilitation, preventive medicine, nutritional science, physical conditioning, and advanced diagnostic imaging. By combining these disciplines within a coordinated care model, clinicians can help survivors restore functional independence, improve long-term health outcomes, and regain confidence in their physical abilities.

Surviving cancer represents a significant medical achievement. Helping individuals reclaim an active, productive, and fulfilling life thereafter represents the next evolution of comprehensive cancer care.

About the Author

Robert L. Bard, MD, is an internationally recognized diagnostic imaging specialist and pioneer in advanced non-invasive cancer imaging. For more than five decades, he has dedicated his career to improving the early detection, characterization, and surveillance of cancer through innovative applications of 3D Doppler ultrasound, MRI, and image-guided technologies. Dr. Bard has authored numerous scientific publications, lectures internationally, and collaborates with multidisciplinary teams advancing precision diagnostics, survivorship, and preventive medicine. His clinical philosophy emphasizes early detection, active surveillance, and personalized imaging strategies that empower patients throughout every stage of cancer care and long-term recovery. Learn more at www.thecancerdetective.org.

PART 3

COMING HOME TO YOURSELF: The Journey Beyond Cancer Survival

By Anette DeMattio, MA

 

In the first two articles of this series, Jessica Connell and Dr. Barbara Bartlik explored what happens to the mind after cancer, while Dr. Robert Bard explored what happens to the body.

Reading them, I exhaled.

For the first time in more than thirty years, I understood what had happened to me. Not just to my body but to the way I think, the way I remember, the way I move through the world.  In six cancer diagnoses across a lifetime, no one had ever told me that what I was experiencing after treatment had a name. That I wasn’t imagining it. That I wasn’t failing at recovery. Recovery wasn’t simply about healing my brain. It was about rebuilding my relationship with it. Treatment ends. Recovery doesn’t.

I’d like to offer the view from inside, and to ask you to walk this part of the journey with me, because I don’t believe any of us were meant to walk it alone.

I still search for words. Every day.

There was a time when I could facilitate a room full of executives, coach leaders through life-changing decisions, and juggle six projects without thinking twice. Today, I keep twenty-five tabs open on my screen because I’m afraid that if I close one, I’ll forget where I was.

Reading their description of the lasting cognitive effects of cancer,  shaped not only by chemotherapy but by chronic stress and the burden of surviving, gave me something I wish every survivor received far earlier.

Self-compassion. I wasn’t weak. My brain and nervous system had been surviving for years. Recovery wasn’t simply about healing. It was about rebuilding trust. If I had known this thirty years ago, I would have been gentler with myself. I wasn’t only grieving what my brain could no longer do. I was grieving the woman I thought I’d lost.

And that kind of loss? When you lose confidence in your own mind, you slowly begin losing confidence in yourself. Yet for many survivors, it becomes one of the deepest wounds cancer leaves behind. Because cancer isn't only a diagnosis. It's a trauma the body remembers long after treatment ends.

I realized that on an ordinary afternoon. An executive sat across from me, complaining that money was tight and he wouldn’t be able to use his boat that summer. I remember listening. I remember another conversation happening entirely inside my own head. You want to know suffering? Try being a single mother of two young daughters, facing cancer for the fifth time while worrying about their health too.

The thought startled me. For my whole career, my gift had always been helping people carry their hardest moments. That day, I couldn’t carry another. I thought I’d lost my compassion. I hadn’t. I was exhausted. The woman who had spent decades carrying everyone else had finally reached the point where she could no longer carry herself. That afternoon became my last day in corporate work.

For me, it was work. Later, it was a relationship I finally let go of. For someone else, it may be something entirely different. But there is often a moment when the life we’ve been holding together can no longer hold us. And what changes isn’t our circumstances. It’s our identity.

What no one tells you is how lonely survivorship can become. I spent a small fortune trying to piece myself back together. Some of it helped. None of it gave me what these articles finally did. Language. Because once we can name an experience, we stop believing we’re the only one living it. Shame begins to loosen. Slowly, we begin trusting ourselves again.

We often talk about surviving. Then thriving. Both matter. But I have come to believe there is one more step. Evolving. Cancer didn’t teach me who I was. It slowly stripped away who I wasn’t. Long before anyone found a tumor, I’d already become an expert at surviving. Pushing through. Performing strength. Believing my worth lived in how much I could carry. Cancer didn’t create those patterns. It revealed them. The problem was never that I became strong. The problem was that I forgot strength was an adaptation — not my identity.

The first two articles remind us that survivorship is about more than the absence of disease. I’d simply add one more dimension. The rehabilitation of the self. Because after treatment ends, it isn’t only our bodies and minds that need rebuilding. It’s the relationship we’ve lost with ourselves. Trust in our minds. Trust in our bodies. Trust in ourselves. Because trust isn’t the destination. It’s the bridge back to the self beneath survival.

Looking back, I don’t think what nearly broke me was cancer. It was believing I had to become the woman I had been before it. She no longer existed. And maybe she was never meant to. Maybe the deepest work of survivorship isn’t returning to who we were before cancer. It’s allowing everything survival built around us to fall away, until all that’s left is the truest version of ourselves. The one that was there underneath it all — long before the diagnosis, long before survival became our identity. Waiting patiently for us to come home.

ABOUT THE AUTHOR:

Anette DeMattio is a six-time cancer survivor, author, speaker, and transformational coach whose work explores the profound emotional journey beyond survival. Drawing from decades of leadership coaching and her own lived experience with cancer and chronic pain, she developed The Too Strong Method™, helping individuals recognize the hidden cost of always being "the strong one." Her writing challenges traditional notions of recovery by emphasizing the restoration of identity, self-trust, and authentic living. Through compassionate insight and personal wisdom, Anette inspires survivors, caregivers, healthcare professionals, and leaders to move beyond resilience and rediscover the truest version of themselves.

 

A LEGACY OF SERVICE, INNOVATION & HOPE

MBCGA Honors Dr. Robert L. Bard with Lifetime Achievement Award

On June 10, 2026, an extraordinary gathering of physicians, advocates, researchers, wellness leaders, patients, colleagues, and friends came together for a singular purpose: to celebrate the remarkable career and enduring legacy of Dr. Robert L. Bard.

In a heartfelt ceremony hosted by the Male Breast Cancer Global Alliance (MBCGA), Dr. Bard was presented with the organization's prestigious Lifetime Achievement Award, recognizing decades of groundbreaking contributions to diagnostic imaging, cancer detection, patient advocacy, medical education, and clinical innovation.

The celebration was organized through the collaborative efforts of MBCGA Chief Executive Officer Cheri Ambrose, AngioInstitute Executive Director Lennard Goetze, and Dr. Bard's dedicated office leadership team, including Aimee Arceo and Mary Ann Santa Rita. More than forty supporters participated in the event, with many gathering in person at Dr. Bard's East 60th Street office in New York City while others joined virtually from across the country and around the world.

Among those attending virtually were advocates, clinicians, researchers, wellness leaders, and longtime friends including Dr. Angela Mazza, Dr. Barbara Bartlik, Dr. Noelle Cutter, Dr. Jennifer Letitia, Dr. Hwaida Hannoush, Dr. Jay Harness, Dr. Leslie Valle-Montoya, Faye Davis, Andrea Leonard, Coach Jenny Horne, Ed Kraft, Patrick Ziemer, Barrie Kolstein, Dave Dachinger and family, Daniel Root, and many others whose lives and careers have intersected with Dr. Bard's over the years. These voices represented a powerful testament to the reach of his influence and the respect he commands throughout the healthcare community.

A Lifetime Achievement Award represents far more than recognition for years of service. It honors a body of work that has transformed a profession, elevated standards of care, and improved the lives of countless individuals. It recognizes a legacy built through sustained excellence, leadership, and dedication to a cause greater than oneself.

For Dr. Bard, that legacy spans decades of pioneering work in diagnostic ultrasound, Doppler imaging, elastography, thermology, and non-invasive cancer diagnostics. Long before many advanced imaging techniques became mainstream, he recognized their potential to provide earlier answers, greater precision, and improved outcomes for patients. His commitment to innovation has continually challenged conventional thinking while advancing the field of diagnostic medicine.

The Male Breast Cancer Global Alliance chose to honor Dr. Bard not only for his scientific achievements but also for his unwavering support of patients living with breast cancer—particularly men, a population that has historically been overlooked in cancer awareness and screening efforts. As a clinical advisor, educator, and advocate, Dr. Bard has helped elevate awareness of male breast cancer, contributed to research initiatives, supported educational programs, and encouraged earlier detection strategies that continue to save lives.

One of the evening's most memorable moments came when retired firefighter and longtime friend Salvatore "Cousin Sal" Banchitta stepped forward to formally present Dr. Bard with the Lifetime Achievement Award trophy.

"Dr. Bard represents the kind of service that never retires," said Banchitta. "He has spent his life showing up for people, finding answers, and giving hope where hope was needed most. Tonight, we are not just honoring a doctor—we are honoring a man whose life's work has changed lives." The presentation was met with a standing ovation as attendees reflected on the extraordinary impact Dr. Bard has made through decades of service to medicine and humanity.

Adding to the celebration was a special tribute from wellness advocate and entrepreneur Russ Allen of Wellness Now. Allen presented Dr. Bard with a unique commemorative gift: an autographed NFL football representing "Pro Legends." The football symbolized many of the qualities that define both championship athletes and exceptional physicians—discipline, perseverance, leadership, resilience, and an unwavering commitment to excellence.

"Legends are not made in a single season," Allen remarked. "They are built through consistency, courage, sacrifice, and the ability to inspire others. Dr. Bard is a Pro Legend in medicine. His field may be diagnostic imaging, but his real legacy is leadership, service, and impact." The symbolism resonated deeply with those present. Like the athletes whose signatures adorned the football, Dr. Bard has spent a lifetime mastering his craft, overcoming challenges, mentoring future generations, and setting a standard of excellence that others strive to achieve.

Cheri Ambrose, CEO of the Male Breast Cancer Global Alliance, reflected on why honoring individuals such as Dr. Bard remains central to the organization's mission. "Our medical advisors give strength and credibility to our advocacy," Ambrose said. "When physicians like Dr. Bard stand beside us, they help transform awareness into action. Honoring him is our way of saying that science, compassion, and advocacy must work together if we are truly going to change outcomes for men with breast cancer."

As the reception drew to a close, Dr. Bard accepted the award with characteristic humility and gratitude. "I am deeply moved by this recognition," he said. "To be honored by friends, colleagues, advocates, and patients is more meaningful than I can fully express. My work has always been about helping people find answers, and I am grateful to share this mission with all of you. Whatever successes I have achieved have only been possible because of the remarkable people I have had the privilege to work beside throughout my career."

Those remarks reflected a theme repeated throughout the evening. While attendees celebrated Dr. Bard's technological innovations, clinical accomplishments, and contributions to cancer care, they spoke just as passionately about his generosity, mentorship, compassion, and willingness to help others succeed. Indeed, Dr. Bard's greatest legacy may not be found solely in the imaging technologies he advanced or the patients he diagnosed. It lives in the physicians he mentored, the advocates he empowered, the organizations he strengthened, and the countless individuals who found hope through his work.

The Lifetime Achievement Award presented by the Male Breast Cancer Global Alliance serves as a formal recognition of an extraordinary career. More importantly, it stands as a tribute to a life dedicated to service, discovery, and compassion. Through his leadership, vision, and unwavering commitment to improving patient care, Dr. Robert L. Bard has earned not only professional distinction but also the enduring admiration and gratitude of an entire community.

His achievements have shaped the past and continue to influence the future. His legacy is not merely what he has accomplished—it is what he has inspired in others. And that may be the greatest achievement of all.

Pink Bias (A Commentary on Social Un-Consciousness)

When Men with Breast Cancer are Forced Into a System That Was Never Designed for Them

Words and Pictures by: Lennard M. Goetze, Ed.D.

Breast cancer has long been framed within the public consciousness as a disease that primarily affects women. While this perception reflects the overwhelming majority of diagnosed cases, it has also contributed to the unintended marginalization of a smaller yet clinically significant population: men diagnosed with breast cancer. The result is a healthcare environment that often overlooks the unique experiences, emotional burdens, and diagnostic challenges faced by male patients.

Throughout the United States, breast imaging centers, breast health programs, and awareness campaigns have been developed around female-centered models of care. Pink ribbons, women's health messaging, female-focused educational materials, and gender-specific support programs dominate the breast cancer landscape. These initiatives have undoubtedly improved awareness, screening participation, and clinical outcomes for women. However, they have simultaneously created an environment in which men with breast cancer frequently feel invisible.

The issue extends beyond aesthetics or marketing. The predominance of female-oriented breast cancer messaging has contributed to a broader societal misconception that breast cancer is exclusively a woman's disease. Consequently, many men remain unaware that they are at risk. Others delay seeking medical evaluation because symptoms are not immediately associated with breast malignancy. In some cases, the stigma surrounding a traditionally female-associated disease further discourages men from discussing breast health concerns with family members, healthcare providers, or peers.

The consequences of this perception can be significant. Numerous studies have demonstrated that men are frequently diagnosed with breast cancer at later stages compared to women. Delayed diagnosis is often attributed to lower disease awareness, reduced vigilance regarding symptoms, and the absence of routine screening recommendations for the general male population. Because breast cancer is seldom considered during routine health discussions involving men, suspicious findings may remain uninvestigated until the disease becomes clinically advanced.

An additional challenge emerges once a male patient enters the healthcare system. Many breast centers have been designed almost exclusively around female patients. Waiting rooms are often filled with women's health publications, pink-themed décor, and educational materials that make little or no mention of male breast cancer. Although these elements are intended to create supportive environments for women, they may inadvertently communicate to male patients that they are outsiders in a space where they should feel equally welcome.

Personal accounts from male breast cancer survivors frequently illustrate this reality. Men describe entering breast imaging facilities and feeling as though they have arrived at the wrong location. Some report being mistaken for spouses or caregivers accompanying female patients. Others recount awkward interactions with staff members who rarely encounter male breast cancer patients. While such experiences are rarely malicious, they reveal a systemic lack of familiarity with the disease in men and reinforce feelings of isolation during an already stressful period.

One survivor described arriving for a mammography appointment only to be asked by a receptionist whether he was lost. When he responded that he was there for a mammogram, the expression on the receptionist's face immediately changed. Although the interaction was brief, it highlighted a larger issue: many healthcare professionals, like members of the public, unconsciously associate breast cancer exclusively with women. The survivor later raised this concern during a patient feedback session. To the institution's credit, educational posters addressing male breast cancer were subsequently added throughout the facility. The experience demonstrated how awareness can improve when organizations actively listen to patient perspectives.

Diagnostic imaging presents another area in which male patients encounter unique challenges. Mammography remains the cornerstone of breast cancer detection and evaluation. However, the technology and procedural protocols were developed primarily around female anatomy. Men possess substantially less breast tissue, different chest wall structures, and greater muscular development across the pectoral region. As a result, imaging procedures may be more technically challenging and physically uncomfortable for male patients.

Beyond the imaging equipment itself, post-procedural experiences may further reinforce feelings of exclusion. Several survivors have humorously described being provided with garments, wraps, or post-surgical accessories available only in traditionally feminine colors or designs. While seemingly minor, such details contribute to a broader perception that male breast cancer patients are being accommodated within a system built for someone else rather than receiving care specifically designed with their needs in mind.

The emotional implications of these experiences should not be underestimated. Research increasingly recognizes that patient-centered care extends beyond clinical outcomes. Feelings of belonging, dignity, representation, and inclusion influence healthcare engagement and compliance. When patients perceive themselves as outsiders, they may be less likely to participate in follow-up care, support programs, or early diagnostic evaluations. In the context of breast cancer, where early detection remains one of the strongest predictors of favorable outcomes, such barriers can have serious consequences.

Importantly, addressing male breast cancer awareness does not require diminishing the accomplishments of women's breast cancer advocacy. The remarkable progress achieved through decades of education, fundraising, research, and public outreach has transformed breast cancer care and saved countless lives. Rather than replacing these efforts, the goal should be to expand them. A more inclusive model of breast cancer awareness acknowledges that although men represent a minority of cases, their experiences are equally valid and deserving of recognition.

Healthcare organizations can take meaningful steps toward reducing this disparity. Educational materials should routinely acknowledge male breast cancer. Awareness campaigns should include male imagery and survivor stories. Breast imaging centers should ensure that informational resources address both genders. Healthcare providers should discuss breast cancer risk factors with high-risk male patients, particularly those with family histories, BRCA mutations, genetic syndromes, or prior radiation exposure.

Ultimately, breast cancer does not discriminate based on gender. The biological reality of the disease demands a healthcare response that is equally inclusive. Until awareness campaigns, clinical environments, and diagnostic pathways fully recognize the existence of male breast cancer patients, many men will continue to face unnecessary barriers to care.

The challenge before the healthcare community is not merely improving detection rates; it is ensuring that every patient who walks through the doors of a breast center feels acknowledged, respected, and represented. In the pursuit of equitable cancer care, eliminating "Pink Bias" may be one of the most important conversations that has yet to occur.

------------------------------------------------------------------------------------------------------------------------

© 2026 Lennard M. Goetze. All Rights Reserved. This article and all accompanying artwork, illustrations, graphics, and visual content are protected by copyright law. Permission is granted solely for publication within this specific newsletter issue. No rights are granted for reproduction, republication, redistribution, syndication, archival use, digital posting, adaptation, or reuse of any content contained herein by any other publisher, organization, entity, or individual without the prior written consent of Lennard M. Goetze. Any unauthorized use of this material, in whole or in part, is strictly prohibited.

------------------------------------------------------------------------------------------------------------------------

The Consequences of Invisibility: Why Male Breast Cancer Must Become Part of the National Conversation

By Cheri Ambrose / Founder, Male Breast Cancer Global Alliance

The article "Pink Bias"- highlights a challenge that those of us involved in male breast cancer advocacy encounter with remarkable frequency. Although breast cancer awareness has expanded significantly over the past several decades, public understanding of male breast cancer has not advanced at the same pace. Consequently, many men continue to experience barriers to awareness, diagnosis, treatment, and survivorship support that are rarely acknowledged within mainstream breast cancer discourse.

As an advocate working directly with male breast cancer patients, survivors, caregivers, and healthcare professionals, I routinely hear accounts that mirror those presented in this article. Men describe delays in seeking medical attention because they were unaware that breast cancer could occur in males. Others report confusion among family members, employers, and even healthcare personnel when confronted with a diagnosis generally perceived as a disease affecting women. These experiences are not merely anecdotal observations; collectively, they reflect a systemic awareness deficit that continues to affect patient outcomes.

The issue extends beyond public perception. Male breast cancer patients frequently enter healthcare environments that have been developed almost exclusively around female patients. Educational materials, awareness campaigns, support services, and even the physical design of breast centers often assume a female audience. While these resources have contributed substantially to advances in women's breast health, they may unintentionally reinforce the perception that men are exceptions rather than legitimate members of the breast cancer community.

This lack of visibility has practical consequences. Early detection remains one of the most important determinants of successful treatment outcomes. However, early detection depends upon awareness. Individuals who do not recognize their risk are less likely to seek evaluation for suspicious symptoms. Healthcare providers who rarely encounter male breast cancer may be less likely to discuss risk factors with male patients or incorporate breast health education into routine care. The result is a diagnostic pathway that frequently begins later than it should.

An equally important concern involves survivorship. Many male patients report difficulty locating peer support, educational resources, or advocacy programs specifically addressing their experiences. Although men and women share many clinical aspects of breast cancer treatment, the psychosocial dimensions of the disease can differ significantly. Feelings of isolation, stigma, and exclusion are frequently reported by male survivors and warrant greater attention within survivorship programming.

Importantly, addressing these disparities should not be viewed as competing with or diminishing efforts focused on women's breast health. The achievements of breast cancer advocacy organizations over the past several decades have transformed awareness, funding, research, and patient care. Rather, the challenge before us is one of inclusion. A comprehensive breast cancer awareness strategy should recognize and address the needs of all individuals affected by the disease.

Progress is achievable. Healthcare institutions can incorporate male breast cancer education into patient materials and awareness campaigns. Professional organizations can expand educational efforts directed toward clinicians. Researchers can continue investigating optimal screening and surveillance strategies for high-risk male populations. Advocacy groups can ensure that survivor narratives reflect the full diversity of the breast cancer community.

The stories described in Pink Bias are not isolated experiences. They represent opportunities for improvement. By acknowledging the existence of male breast cancer and incorporating men into awareness, education, and support initiatives, the healthcare community can move toward a more equitable model of breast cancer care.

Ultimately, visibility is not merely a matter of representation. It is a matter of public health. Men who understand their risk are more likely to seek evaluation. Healthcare providers who recognize the disease are more likely to diagnose it promptly. Institutions that embrace inclusivity are more likely to provide supportive and effective care. For these reasons, increasing awareness of male breast cancer should be viewed not as a symbolic gesture, but as an essential component of improving outcomes for an underserved patient population.

Disclaimer & Copyright Notice: The materials provided on this web-based article are copyrighted and the intellectual property of the publishers/producers (The MBC Global Alliance). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

The information provided in this article is a compiled report from public websites whose links are listed in the FOOTNOTES OR REFERENCE section and the statements and quotes included are from actual interviews by those whose names are stated who provided express consent to the publishing of this material.  This article is not meant to be used to diagnose, treat or advise others about what actions they should take with regard to any medical condition.  No one should undertake or discontinue any treatment as a result of what they read on our blogs. The publisher(s), editors or sponsors  are providing a strictly educational or editorial service and are not responsible for the diagnosis or treatment of any specific health needs. Writers and publishers are not liable for any damages or negative consequences from any treatment, action, application or preparation to any person(s) reading the information in this article or its thread. Readers with medical needs should obtain appropriate professional medical supervision. References are provided for any informational purposes only and do not constitute endorsement of any websites or other sources.